D L Carlson Investment Group »

Cerevel Therapeutics Hldng I shares owned by D L Carlson Investment Group

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by D L Carlson Investment Group from 13F filings

Historical chart of D L Carlson Investment Group investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by D L Carlson Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by D L Carlson Investment Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $322k 7.5k 42.93

More positions owned by D L Carlson Investment Group

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Ishares Tr Intrm Gov Cr Etf (GVI)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Select Sector Spdr Tr Energy (XLE)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Wingstop (WING)
Ishares Tr Msci Eafe Etf (EFA)
Toll Brothers (TOL)
JPMorgan Chase & Co. (JPM)

View all positions for D L Carlson Investment Group

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I